Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
(Approval lapsed) IMOJEV japanese encephalitis vaccine (live, attenuated) powder for injection vial plus diluent vial (Thailand presentation)
Section 19A approved medicine
(Approval lapsed) IMOJEV japanese encephalitis vaccine (live, attenuated) powder for injection vial plus diluent vial (Thailand presentation)
Section 19A approval holder
Sanofi-Aventis Australia Pty Ltd ABN 31 008 558 807
Phone
1800 818 806
Approved until
Status
Expired
Medicines in short supply/unavailable
IMOJEV japanese encephalitis vaccine (live, attenuated) powder for injection vial plus diluent vial AUST R: 162215
Indication(s)
Indicated for prophylaxis of Japanese encephalitis caused by the Japanese encephalitis virus, in individuals from 9 months of age and over.
Images
